OVCA
Showing 1 - 19 of 19
Ovarian Tumors, Ovarian Epithelial Cancer Trial in Czechia, Poland (DCVAC/OvCa with Standard of Care, DCVAC/OvCa sequentially
Completed
- Ovarian Neoplasms
- Ovarian Epithelial Cancer
- DCVAC/OvCa with Standard of Care
- +2 more
-
Brno, Czechia
- +12 more
May 3, 2022
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial (DCVAC/OvCa, DCVAC/OvCa )
Withdrawn
- Ovarian Cancer
- +2 more
- DCVAC/OvCa
- DCVAC/OvCa placebo
- (no location specified)
Dec 6, 2021
Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Beijing (DCVAC/OvCa, Placebo)
Recruiting
- Epithelial Ovarian Carcinoma
- +2 more
- DCVAC/OvCa
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Apr 30, 2021
Ovarian Cancer Recurrent Trial in Czechia (DCVAC/OvCa, Standard of Care Chemotherapy)
Completed
- Ovarian Cancer Recurrent
- DCVAC/OvCa
- Standard of Care Chemotherapy
-
Brno, Czechia
- +7 more
Apr 20, 2021
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Ovarian Tumors, Ovarian Cancer (OvCa), Ovarian Epithelial Cancer Trial in Czechia, Germany, Poland (DCVAC/OvCa in parallel with
Completed
- Ovarian Neoplasms
- +2 more
- DCVAC/OvCa in parallel with chemotherapy
- Standard of Care
-
Brno, Czechia
- +15 more
Aug 13, 2018
Ovarian Cancer Trial in St.-Petersburg (chemo/surgery)
Recruiting
- Ovarian Cancer
- chemotherapy/surgery
-
St.-Petersburg, Pesochny-2, St.-Petersburg, Russian FederationNMRC of Oncology named after N.N.Petrov of MoH of Russia
Feb 10, 2021
Ovarian Cancer Trial in Tampa (Triciribine, Carboplatin)
Terminated
- Ovarian Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 22, 2020
Quality of Life Associated WithLow-Risk Screening Program for
Unknown status
- Ovarian Cancer
- Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 20, 2019
High-Risk Cancer Trial in Milan (Fenretinide, Placebo)
Terminated
- High-Risk Cancer
- Fenretinide
- Placebo
-
Milan, ItalyEuropean Institute of Oncology
Nov 6, 2018
Epithelial Ovarian Carcinoma Trial in Czech Republic, Germany, Poland (DCVAC/OvCa, Standard of Care (Paclitaxel or topotecan or
Terminated
- Epithelial Ovarian Carcinoma
- DCVAC/OvCa
- Standard of Care (Paclitaxel or topotecan or doxorubicin)
-
Brno, Czech Republic
- +11 more
Nov 29, 2016
Ovarian Tumors, Fallopian Tube Tumors, Peritoneal Tumors Trial in Tsukiji, 5-1-1, Chuo-ku (Neoadjuvant chemo (Paclitaxel and
Completed
- Ovarian Neoplasms
- +2 more
- Neoadjuvant chemotherapy (Paclitaxel and Carboplatin)
-
Tsukiji, 5-1-1, Chuo-ku, Tokyo, JapanNational Cancer Center
Aug 30, 2016
Advanced Ovarian Cancer Trial in Seoul (Neoadjuvant chemo, Carboplatin)
Completed
- Advanced Ovarian Cancer
- Neoadjuvant chemotherapy
- Carboplatin
-
Seoul, Korea, Republic ofAsan Medical Center
May 27, 2017
Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin
Unknown status
- Epithelial Ovarian Cancer
-
Seoul, Korea, Republic ofDepartment of Obstetrics and Gynecology, University of Ulsan Col
May 27, 2017
Ovarian Cancer Trial in Canada, United States (carboplatin, gemcitabine HCl)
Completed
- Ovarian Cancer
- carboplatin
- gemcitabine hydrochloride
-
Duluth, Minnesota
- +73 more
Dec 22, 2015